MANAC Chemical Partners Co.,Ltd AI Stock Analysis
Want to see JP:4360 full AI Analyst Report?
MANAC Chemical Partners Co.,Ltd (4360) AI Stock Analysis
MANAC Chemical Partners Co.,Ltd
(TSE/TYO:4360)
The overall score is driven by MANAC Chemical Partners' highly attractive valuation and robust financial turnaround, which heavily outweigh near-term technical weakness. An exceptionally low P/E ratio of 8.02 and a low-leverage balance sheet highlight a compelling value proposition with minimal financial downside. While short-term price momentum is slightly bearish as it trades below short-term moving averages, the company's return to profitability and strong free cash flow generation provide a highly resilient foundation for long-term investors.
MANAC Chemical Partners Co.,Ltd (4360) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 7.40B
- Dividend Yield
- 1.64%
- Average Volume (3M)
- 7,373
- Price to Earnings (P/E)
- 8.4
- Beta (1Y)
- 1.04
- Revenue Growth
- 5.56%
- EPS Growth
- ―
- Country
- Japan
- Employees
- 246
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals
MANAC Chemical Partners Co.,Ltd Business Overview & Revenue Model
Company Description
Operating primarily in Japan, MANAC Chemical Partners Co.,Ltd, along with its subsidiaries, undertakes the comprehensive development, manufacturing, sales, import, and export of industrial chemicals and pharmaceutical products. The company additional...
How the Company Makes Money
MANAC Chemical Partners makes money primarily by selling chemical products it manufactures to business customers (B2B). Revenue is generated through (1) product sales of specialty/fine chemicals (including functional materials and chemical intermedia...
MANAC Chemical Partners Co.,Ltd Financial Statement Overview
Summary
MANAC Chemical Partners exhibits a robust financial profile driven by a successful operational turnaround, returning to solid profitability with impressive cash flow generation. The balance sheet is exceptionally strong with a debt-to-equity ratio of just 7.2%, providing a highly stable foundation and minimizing financial risk.
Income Statement
75PositiveBalance Sheet
88Very PositiveCash Flow
82Very Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.48B | 10.99B | 9.30B | 9.69B | 11.85B | 10.70B |
| Gross Profit | 2.85B | 2.50B | 1.47B | 1.82B | 2.81B | 2.43B |
| EBITDA | 1.50B | 1.11B | -312.00M | 545.00M | 1.62B | 1.19B |
| Net Income | 983.00M | 781.00M | -895.00M | 82.00M | 821.00M | 712.00M |
Balance Sheet | ||||||
| Total Assets | 16.02B | 15.31B | 12.65B | 14.10B | 15.01B | 13.59B |
| Cash, Cash Equivalents and Short-Term Investments | 4.19B | 4.01B | 2.77B | 3.29B | 3.72B | 2.04B |
| Total Debt | 791.00M | 816.00M | 0 | 0 | 290.00M | 291.00M |
| Total Liabilities | 4.32B | 4.00B | 2.34B | 2.85B | 3.97B | 3.29B |
| Stockholders Equity | 11.70B | 11.30B | 10.30B | 11.25B | 11.04B | 10.29B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 531.00M | -411.00M | -593.00M | 1.40B | 30.00M |
| Operating Cash Flow | 0 | 2.15B | 108.00M | -118.00M | 1.65B | 714.00M |
| Investing Cash Flow | 0 | -1.66B | -489.00M | -231.00M | 199.00M | -422.00M |
| Financing Cash Flow | 0 | 727.00M | -126.00M | -75.00M | -125.00M | -200.00M |
MANAC Chemical Partners Co.,Ltd Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4360, the sentiment is Negative. The current price of 905.00 is below the 20-day moving average (MA) of 970.70, below the 50-day MA of 978.30, and below the 200-day MA of 905.05, indicating a neutral trend. The MACD of -10.37 indicates Positive momentum. The RSI at 40.19 is Neutral, neither overbought nor oversold. The STOCH value of 28.60 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4360.
MANAC Chemical Partners Co.,Ltd Peers Comparison
Overall Rating
JP:436077Outperform
JP:404067Neutral
JP:656863Neutral
JP:496051Neutral
JP:453149Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | JPY 7.88B | 8.38 | ― | 1.64% | 5.56% | ― | |
| 67Neutral | JPY 8.94B | 2.34 | ― | 1.73% | -0.40% | 215.27% | |
| 63Neutral | JPY 9.86B | 10.12 | ― | 2.60% | 23.75% | 40.75% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 51Neutral | JPY 7.40B | 19.43 | ― | 1.11% | 6.87% | 300.65% | |
| 49Neutral | JPY 6.90B | 14.18 | ― | 3.16% | 3.90% | -31.32% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4360 | MANAC Chemical Partners Co.,Ltd | 905.00 | 297.57 | 48.99% | |
| JP:4040 | NANKAI CHEMICAL COMPANY LIMITED | 3705.00 | 780.16 | 26.67% | |
| JP:4531 | Yuki Gosei Kogyo Co., Ltd. | 313.00 | 35.04 | 12.61% | |
| JP:4960 | Chemipro Kasei Kaisya,Ltd. | 452.00 | 137.37 | 43.66% | |
| JP:6568 | KNC Laboratories Co.,Ltd. | 1270.00 | 198.67 | 18.54% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 12, 2026
